The Discounted Cash Flow (DCF) valuation of Wakamoto Pharmaceutical Co Ltd (4512.T) is 109.15 JPY. With the latest stock price at 293.00 JPY, the upside of Wakamoto Pharmaceutical Co Ltd based on DCF is -62.7%.
Based on the latest price of 293.00 JPY and our DCF valuation, Wakamoto Pharmaceutical Co Ltd (4512.T) is a sell. selling 4512.T stocks now will result in a potential gain of 62.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.4% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 92.59 - 314.56 | 109.15 |
| Upside | -68.4% - 7.4% | -62.7% |